Cargando…
Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
SIMPLE SUMMARY: Stroma-targeting therapy in pancreatic ductal adenocarcinoma (PDAC) has been extensively investigated, but no candidates have shown efficacy at the clinical trial stage. Studies of cancer-associated fibroblast (CAF) depletion in a mouse model suggested that CAFs have not only tumor-p...
Autores principales: | Shinkawa, Tomohiko, Ohuchida, Kenoki, Nakamura, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406547/ https://www.ncbi.nlm.nih.gov/pubmed/36010986 http://dx.doi.org/10.3390/cancers14163994 |
Ejemplares similares
-
Repositioning of duloxetine to target pancreatic stellate cells
por: Sagara, Akiko, et al.
Publicado: (2021) -
Efficient pre-treatment for pancreatic cancer using chloroquine-loaded nanoparticles targeting pancreatic stellate cells
por: Matsumoto, Sokichi, et al.
Publicado: (2021) -
Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses
por: Shinkawa, Tomohiko, et al.
Publicado: (2022) -
Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
por: Sunami, Yoshiaki, et al.
Publicado: (2021) -
Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue
por: Arima, Yoshimi, et al.
Publicado: (2023)